
TY  - JOUR
TI  - ABSTRACTS OF PAPERS PRESENTED AT THE 26th ANNUAL MEETING OF THE AUSTRALIAN COLLEGE OF PAEDIATRICS MAY, 1981
JO  - Journal of Paediatrics and Child Health
VL  - 17
IS  - 2
SN  - 1034-4810
UR  - https://doi.org/10.1111/j.1440-1754.1981.tb01920.x
DO  - doi:10.1111/j.1440-1754.1981.tb01920.x
SP  - 125
EP  - 149
PY  - 1981
ER  - 

TY  - JOUR
TI  - Poster abstracts
JO  - Acta Neuropsychiatrica
VL  - 21
IS  - s2
SN  - 0924-2708
UR  - https://doi.org/10.1111/j.1601-5215.2009.00387.x
DO  - doi:10.1111/j.1601-5215.2009.00387.x
SP  - 73
EP  - 94
PY  - 2009
ER  - 

TY  - JOUR
AU  - MANGER, WILLIAM M.
TI  - An Overview of Pheochromocytoma
JO  - Annals of the New York Academy of Sciences
VL  - 1073
IS  - 1
SN  - 0077-8923
UR  - https://doi.org/10.1196/annals.1353.001
DO  - doi:10.1196/annals.1353.001
SP  - 1
EP  - 20
KW  - familial
KW  - metanephrine
KW  - normetanephrine
KW  - imaging
KW  - treatment
PY  - 2006
AB  - Abstract:? Tragically as many as 50% of pheochromocytomas are discovered at autopsy, mainly because the diagnosis of this neuroendocrine tumor was not considered. Missing the diagnosis almost invariably results in devastating cardiovascular complications or death. Clinicians must always think of pheochromocytoma whenever evaluating a patient with sustained or paroxysmal hypertension or any manifestations suggesting hypercatecholaminemia. Very rarely, familial pheochromocytomas may cause no hypertension, symptoms, or signs. But biochemical testing can always establish the presence or absence of a pheochromocytoma, and localization with magnetic resonance imaging, computed tomography, or 131I or 123I-MIBG is almost always possible.
ER  - 

TY  - JOUR
TI  - Toxicology
JO  - Basic & Clinical Pharmacology & Toxicology
JA  - Basic Clin Pharmacol Toxicol
VL  - 115
IS  - s1
SN  - 1742-7835
UR  - https://doi.org/10.1111/bcpt.12259_15
DO  - doi:10.1111/bcpt.12259_15
SP  - 350
EP  - 369
PY  - 2014
ER  - 

TY  - JOUR
TI  - Research Communications of the 24th ECVIM-CA Congress
JO  - Journal of Veterinary Internal Medicine
JA  - J Vet Intern Med
VL  - 29
IS  - 1
SN  - 0891-6640
UR  - https://doi.org/10.1111/jvim.12491
DO  - doi:10.1111/jvim.12491
SP  - 423
EP  - 483
PY  - 2015
ER  - 

TY  - JOUR
TI  - Poster Presentations
JO  - BJOG: An International Journal of Obstetrics & Gynaecology
JA  - BJOG: Int J Obstet Gy
VL  - 120
IS  - s3
SN  - 1470-0328
UR  - https://doi.org/10.1111/1471-0528.12496
DO  - doi:10.1111/1471-0528.12496
SP  - 3
EP  - 64
PY  - 2013
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - BJU International
VL  - 109
IS  - s7
SN  - 1464-4096
UR  - https://doi.org/10.1111/j.1464-410X.2012.11177.x
DO  - doi:10.1111/j.1464-410X.2012.11177.x
SP  - 14
EP  - 56
PY  - 2012
ER  - 

TY  - JOUR
AU  - Courteau, C
AU  - Samman, K
AU  - Ali, N
AU  - Riley, P
AU  - Wintermark, P
TI  - Macrosomia and haemodynamic instability may represent risk factors for subcutaneous fat necrosis in asphyxiated newborns treated with hypothermia
JO  - Acta Paediatrica
JA  - Acta Paediatr
VL  - 105
IS  - 9
SN  - 0803-5253
UR  - https://doi.org/10.1111/apa.13463
DO  - doi:10.1111/apa.13463
SP  - e396
EP  - e405
KW  - Birth asphyxia
KW  - Neonatal encephalopathy
KW  - Subcutaneous fat necrosis
PY  - 2016
AB  - Abstract Aim To identify additional risk factors other than asphyxia and hypothermia in newborns developing subcutaneous fat necrosis (SCFN). Methods We conducted a prospective cohort study of all term asphyxiated newborns treated with hypothermia from 2008 to 2015. The presence and location of SCFN were recorded at the time of discharge or at follow-up visits. To identify the risk factors for developing SCFN, we compared the perinatal characteristics of those newborns who developed SCFN with those who did not. Results The newborns developing SCFN had significantly higher birthweights compared with those newborns who did not develop SCFN. Among the newborns with a birthweight equal or superior to the 90th percentile, those who developed SCFN had a significantly higher use of inotropic support and higher maximum troponin levels during their initial hospitalisation. Conclusion A higher birthweight represented an independent risk factor for developing SCFN in asphyxiated newborns treated with hypothermia. When macrosomia is present, other risk factors related to haemodynamic instability during the initial hospitalisation may also increase the risk of developing SCFN.
ER  - 

AU  - Meyer, Rosan
AU  - Marino, Luise
C7  - pp. 66-80
TI  - Nutrition in Critically Ill Children
SN  - 9780470659984
UR  - https://doi.org/10.1002/9781118915349.ch5
DO  - doi:10.1002/9781118915349.ch5
SP  - 66-80
KW  - anthropometry
KW  - biochemical markers
KW  - bolus feeding
KW  - critically ill children (CIC)
KW  - metabolic changes
KW  - nasogastric feeding
KW  - nasojejunal feeding
KW  - nutritional management
KW  - probiotics
PY  - 2016
AB  - Summary Nutritional management of critically ill children (CIC) is a very specialist and challenging area in paediatric practice. A knowledge of metabolic changes and fuel utilisation during physiological stress can assist dietitians in commencing nutritional support at the appropriate time and suggesting a suitable feeding route and feed composition. Critical illness is characterised by a cascade of endocrine and metabolic reactions, affecting all major organs. During critical illness immune cells, e.g. macrophages, lymphocytes and neutrophils, regulate the inflammatory response through the release of cytokines and chemokines. Anthropometry, biochemical markers, clinical and dietary review form part of the nutritional assessment in CIC. This chapter describes the effect of nasogastric versus nasojejunal feeding and continuous feeds versus bolus feeding. A probiotics is a live microbial feed supplement which beneficially affects the host by improving its intestinal microbial balance.
ER  - 

TY  - JOUR
TI  - ASBMR 31st Annual Meeting SA0001–SA0464
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 24
IS  - S1
SN  - 9780470659984
UR  - https://doi.org/10.1002/jbmr.5650241303
DO  - doi:10.1002/jbmr.5650241303
SP  - S150
EP  - S236
PY  - 2009
ER  - 

TY  - JOUR
TI  - 2006 Abstracts: Twenty-Eighth Annual Meeting of the American Society for Bone and Mineral Research: Pennsylvania Convention Convention Center Philadelphia, Pennsylvania, USA, September 15–19, 2006
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 21
IS  - S1
SN  - 9780470659984
UR  - https://doi.org/10.1002/jbmr.5650211407
DO  - doi:10.1002/jbmr.5650211407
SP  - S252
EP  - S301
PY  - 2006
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Internal Medicine Journal
VL  - 40
IS  - s1
SN  - 9780470659984
UR  - https://doi.org/10.1111/j.1445-5994.2010.02187.x
DO  - doi:10.1111/j.1445-5994.2010.02187.x
SP  - 66
EP  - 185
PY  - 2010
ER  - 

AU  - Wilkinson, Roger
C7  - pp. 141-186
TI  - Clinical Pathology
SN  - 9781405108898
UR  - https://doi.org/10.1002/9780470698877.ch7
DO  - doi:10.1002/9780470698877.ch7
SP  - 141-186
KW  - pathology
KW  - haematology
KW  - cytology
KW  - hydration status
KW  - bacteriology
PY  - 2010
AB  - Summary This chapter contains section titled: Blood Sampling Haematology Blood Biochemistry Assessing Hydration Status Coagulation Parameters Bone Marrow Biopsy Cytology Parasitology and Faecal Examination Urinalysis Histopathology Toxicology Virology Bacteriology Mycoplasmata Mycology Mycobacteria
ER  - 

TY  - JOUR
TI  - Abstracts from the XXXVIII Congress of the European Society for Artificial Organs (ESAO 2011) and IV Biennial Congress of the International Federation on Artificial Organs (IFAO 2011)
JO  - Artificial Organs
VL  - 35
IS  - 9
SN  - 9781405108898
UR  - https://doi.org/10.1111/j.1525-1594.2011.01335.x
DO  - doi:10.1111/j.1525-1594.2011.01335.x
SP  - A49
EP  - A141
PY  - 2011
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - HPB
VL  - 12
IS  - s1
SN  - 9781405108898
UR  - https://doi.org/10.1111/j.1477-2574.2010.00165.x
DO  - doi:10.1111/j.1477-2574.2010.00165.x
SP  - 1
EP  - 468
PY  - 2010
ER  - 

TY  - JOUR
TI  - Abstracts cont.
JO  - Clinical Microbiology and Infection
VL  - 11
IS  - s2
SN  - 9781405108898
UR  - https://doi.org/10.1111/j.1469-0691.2005.clm_1134_02.x
DO  - doi:10.1111/j.1469-0691.2005.clm_1134_02.x
SP  - 238
EP  - 390
PY  - 2005
ER  - 

TY  - JOUR
TI  - Abstracts from the American College of Clinical Pharmacy 2012 Virtual Poster Symposium, May 22–24, 2012
JO  - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
JA  - Pharmacotherapy
VL  - 32
IS  - 5
SN  - 9781405108898
UR  - https://doi.org/10.1002/j.1875-9114.2011.01136.x
DO  - doi:10.1002/j.1875-9114.2011.01136.x
SP  - e108
EP  - e133
PY  - 2012
ER  - 

TY  - JOUR
TI  - Elevator Pitch Presentation
JO  - Transplant International
JA  - Transpl Int
VL  - 32
IS  - S2
SN  - 9781405108898
UR  - https://doi.org/10.1111/tri.13510
DO  - doi:10.1111/tri.13510
SP  - 264
EP  - 278
PY  - 2019
ER  - 

TY  - JOUR
AU  - Tan, Walter A.
AU  - Chough, Simon
AU  - Saito, Jerel
AU  - Wholey, Mark H.
AU  - Eles, Gustav
TI  - Covered stent for renal artery aneurysm
JO  - Catheterization and Cardiovascular Interventions
JA  - Cathet. Cardiovasc. Intervent.
VL  - 52
IS  - 1
SN  - 9781405108898
UR  - https://doi.org/10.1002/1522-726X(200101)52:1<106::AID-CCD1026>3.0.CO;2-Z
DO  - doi:10.1002/1522-726X(200101)52:1<106::AID-CCD1026>3.0.CO;2-Z
SP  - 106
EP  - 109
KW  - refractory hypertension
KW  - visceral
KW  - angioplasty
KW  - infarction
KW  - bifurcation
PY  - 2001
AB  - Abstract This is a case of a 51-year-old female with difficult-to-control hypertension and a 3-cm renal artery aneurysm. Successful exclusion of this was performed using a prefabricated stent graft. To our knowledge, this is the first report on the use of a prefabricated covered stent for this indication. Cathet Cardiovasc Intervent 2001;52:106?109. ? 2001 Wiley-Liss, Inc.
ER  - 

TY  - JOUR
TI  - Poster Session 4
JO  - European Journal of Heart Failure
JA  - Eur J Heart Fail
VL  - 16
IS  - s2
SN  - 9781405108898
UR  - https://doi.org/10.1002/ejhf.93_21
DO  - doi:10.1002/ejhf.93_21
SP  - 317
EP  - 365
PY  - 2014
ER  - 
